Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 4/20 | 0.73 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.70 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.70 |
| ▸ | GLP1R | P43220 | 12/20 | 0.64 |
| ▸ | GCGR | P47871 | 8/20 | 0.64 |
| ▸ | GIPR | P48546 | 5/20 | 0.64 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.64 |
| ▸ | CCKBR | P32239 | 4/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Corticorelin Acetate SCHEMBL29357284 | 0.91 | CRHR1 (0.72) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL31139952 | 0.91 | CALCR (0.76) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL30658226 | 0.91 | CALCR (0.77) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL31168252 | 0.90 | CALCR (0.73) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL30495780 | 0.90 | CALCR (0.73) | CALCRCRHR1CRHR2GLP1RKEAP1 | |
| SCHEMBL31182769 | 0.89 | CALCR (0.65) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL30437180 | 0.89 | CALCR (0.68) | CALCRGLP1RCCKBR | |
| SCHEMBL31139995 | 0.89 | GLP1R (0.76) | CALCRGLP1RGCGRGIPRCCKBR | |
| SCHEMBL29624204 | 0.89 | CALCR (0.76) | CALCRCRHR1CRHR2GLP1RGCGR | |
| SCHEMBL29413135 | 0.89 | CALCR (0.76) | CALCRCRHR1CRHR2GLP1RGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118510523-A | Peptide nucleic acid degradation complex and use thereof | 维里蒂斯有限责任公司 | 2024-08-16 | — | — | CN | disclosed |